TAMOXIFEN for Neoplasm malignant: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 79 adverse event reports in the FDA FAERS database where TAMOXIFEN was used for Neoplasm malignant.
Most Reported Side Effects for TAMOXIFEN
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Malignant neoplasm progression | 1,499 | 16.5% | 89 | 104 |
| Metastases to bone | 894 | 9.8% | 46 | 53 |
| Fatigue | 729 | 8.0% | 67 | 123 |
| Nausea | 611 | 6.7% | 68 | 222 |
| Metastases to liver | 595 | 6.5% | 44 | 42 |
| Breast cancer | 584 | 6.4% | 23 | 61 |
| Disease progression | 571 | 6.3% | 127 | 74 |
| Breast cancer metastatic | 515 | 5.7% | 26 | 47 |
| Diarrhoea | 512 | 5.6% | 78 | 185 |
| Arthralgia | 497 | 5.5% | 7 | 50 |
| Drug ineffective | 493 | 5.4% | 65 | 84 |
| Pain | 430 | 4.7% | 55 | 105 |
| Off label use | 388 | 4.3% | 59 | 95 |
| Headache | 374 | 4.1% | 51 | 95 |
| Neoplasm progression | 374 | 4.1% | 26 | 52 |
Other Indications for TAMOXIFEN
Breast cancer (2,931)
Product used for unknown indication (1,734)
Breast cancer metastatic (1,054)
Breast cancer female (403)
Invasive ductal breast carcinoma (347)
Her2 positive breast cancer (246)
Hormone receptor positive breast cancer (110)
Hormone therapy (92)
Her-2 positive breast cancer (74)
Breast cancer stage ii (70)
Other Drugs Used for Neoplasm malignant
PALBOCICLIB (1,996)
CAPECITABINE (1,493)
PEMBROLIZUMAB (1,135)
PACLITAXEL (984)
CARBOPLATIN (977)
NIVOLUMAB (947)
OXALIPLATIN (823)
PAZOPANIB (716)
CYCLOPHOSPHAMIDE (685)
FLUOROURACIL (676)